Associate Director, Regulatory Affairs CMC - Hybrid Onsite
AbbVie
About this role
The Associate Director of Regulatory Affairs in CMC at AbbVie is responsible for developing and managing regulatory strategies, preparing submissions, and serving as a liaison with regulatory agencies for small molecule, peptides, and sterile injectable products. The role involves leading initiatives to ensure successful product approvals and maintaining compliance across global regulatory environments.
Skills
About AbbVie
abbvie.caAbbVie is a global biopharmaceutical company (spun out of Abbott in 2013) that discovers, develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology. It is best known for blockbuster brands such as Humira and a growing portfolio that includes targeted biologics and small molecules (and expanded capabilities after the Allergan acquisition). AbbVie emphasizes large-scale R&D, clinical development and strategic partnerships to advance its pipeline and bring therapies to patients worldwide. Headquartered in North Chicago, Illinois, the company operates globally with a focus on long-term innovation and patient outcomes.
About AbbVie
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for AbbVie.
Salary
$137k – $185k
per year
More jobs at AbbVie
Similar Jobs
Associate Director, Regulatory Affairs CMC - Hybrid Onsite
AbbVie
Associate Director, Regulatory Affairs CMC - Hybrid Onsite
AbbVie
Associate Director, Regulatory Affairs CMC - Hybrid Onsite
AbbVie
Associate Director, RA CMC
AbbVie
Director Regulatory Affairs Global CMC
9114 Madaus GmbH
Associate Director, Regulatory Affairs CMC
Acadia Pharmaceuticals Inc.